Skip to content

PROSTATE ONCOLOGY SPECIALISTS

P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM

Menu
  • About
  • Services
  • Prostate Pros
  • Blog
  • Contact

Category: Sky

Sky (Low-Risk) is a relatively harmless condition. The biggest risk for Sky is overtreatment. Within Sky, the most favorable subtype of all (Low-Sky) is defined by all the usual Sky criteria of Gleason 3+3=6, PSA less than 10 and minimal or no palpable disease on DRE. In addition, to qualify as Low-Sky, the PSA density must be less than 0.15, there can be no more than two biopsy cores containing cancer and no single core can be more than 50 percent involved. Men in Low-Sky have the best chance for staying on surveillance long term without requiring treatment. At the other end of the spectrum (within Sky) is High-Sky which is defined by all the usual Sky criteria but with one or more of the following: palpable disease, a PSA density over 0.15 or more than 50% of the biopsy cores containing cancer. These men are at somewhat greater risk for disease progression, i.e., the eventual need to go off active surveillance and undergo treatment. Basic-Sky falls between the Low and High subtypes. As would be expected, the risk for men with Basic-Sky to require future treatment is intermediate between Low and High.

Verywell logo
Advanced / Azure / Elevated / High Risk / Indigo / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Relapsed / Royal / Sky / Stages / Teal

Alternative Therapies for Prostate Cancer

BY MARK SCHOLZ, MD Being diagnosed with cancer often stimulates people into action and triggers powerful survival instincts. Numerous purveyors of alternative medicine cater to these natural fears, and in …

Verywell logo
Advanced / Azure / Elevated / High Risk / Indigo / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Relapsed / Royal / Sky / Stages / Teal / Undiagnosed

10 Myths of Prostate Cancer

BY MARK SCHOLZ, MD I have cared for prostate cancer patients for more than 20 years. Patients come to me with all kinds of wrong notions. Here are 10 of …

Verywell logo
Advanced / Azure / High Risk / Indigo / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Relapsed / Royal / Sky / Teal

10 Ways to Cope With Prostate Cancer: How to Achieve the Best Outcome

BY MARK SCHOLZ, MD Every year, 200,000 men are diagnosed with prostate cancer. Confusion about optimal treatment is widespread. The doctors even defer to their patients saying, “Since it’s about …

Posts navigation

Newer posts

SCHEDULE AN APPOINTMENT

PHONE 310-827-7707
FAX 310-574-4002
mail@prostateoncology.com

  • New Patient Application
  • Education
  • Clinical Trials

Categories

  • Advanced
  • Elevated
  • High Risk
  • Intermediate Risk
  • Low Risk
  • Newly Diagnosed
  • Other
  • Prostate Cancer
  • Relapsed
  • Stages
    • Azure
    • Indigo
    • Royal
    • Sky
    • Teal
  • Undiagnosed

Recent Posts

  • PSA Screening Flowchart
  • A Few Thoughts on Prostatitis
  • Considering Prostate Cancer Clinical Trials? Here’s What You Need to Know
  • Prostate Cancer Spotlights in 2020: A Year in Review
  • Find out about PSMA PET Imaging on Prostate Pros Podcast

Archives

  • April 2021
  • February 2021
  • January 2021
  • December 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • March 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • May 2017
  • February 2017
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • May 2016
  • April 2016
  • February 2016
  • January 2016
  • October 2015
  • November 2012
  • January 2012
  • April 2011
Join our Newsletter
Keep Updated
Copyright © 2025 PROSTATE ONCOLOGY SPECIALISTS – OnePress theme by FameThemes